| Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer G Gandaglia, N Fossati, E Zaffuto, M Bandini, P Dell’Oglio, CA Bravi, ... European urology 72 (4), 632-640, 2017 | 213 | 2017 |
| Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis E Mazzone, A Stabile, F Pellegrino, G Basile, D Cignoli, GO Cirulli, ... European urology oncology 4 (5), 697-713, 2021 | 113 | 2021 |
| Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma A Martini, G Fallara, F Pellegrino, GO Cirulli, A Larcher, A Necchi, ... World journal of urology 39, 1369-1376, 2021 | 43 | 2021 |
| Noninvasive detection of any-stage cancer using free glycosaminoglycans S Bratulic, A Limeta, S Dabestani, H Birgisson, G Enblad, K Stålberg, ... Proceedings of the National Academy of Sciences 119 (50), e2115328119, 2022 | 29 | 2022 |
| Relationship between age, comorbidity, and the prevalence of erectile dysfunction F Pellegrino, DD Sjoberg, AL Tin, NE Benfante, A Briganti, F Montorsi, ... European urology focus 9 (1), 162-167, 2023 | 23 | 2023 |
| Standardising the assessment of patient-reported outcome measures in localised prostate cancer. A systematic review MM Ratti, G Gandaglia, E Alleva, L Leardini, ES Sisca, A Derevianko, ... European urology oncology 5 (2), 153-163, 2022 | 22 | 2022 |
| Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy G Brembilla, S Lavalle, T Parry, M Cosenza, T Russo, E Mazzone, ... European Journal of Radiology 164, 110849, 2023 | 17 | 2023 |
| Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions G Sorce, A Stabile, R Lucianò, G Motterle, S Scuderi, F Barletta, ... BJU international 129 (2), 201-207, 2022 | 15 | 2022 |
| Prostate-specific antigen density cutoff of 0.15 ng/ml/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: efficient threshold or legacy of … F Pellegrino, AL Tin, A Martini, EA Vertosick, SP Porwal, A Stabile, ... European urology focus 9 (2), 291-297, 2023 | 13 | 2023 |
| How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series F Barletta, A Stabile, E Mazzone, G Brembilla, G Sorce, F Pellegrino, ... Urologic Oncology: Seminars and Original Investigations 40 (3), 103. e17-103 …, 2022 | 12 | 2022 |
| How to select the optimal candidates for renal mass biopsy A Martini, A Larcher, CA Bravi, P Capogrosso, UG Falagario, G Fallara, ... European urology oncology 4 (3), 506-509, 2021 | 11 | 2021 |
| Association between lesion location and oncologic outcomes after focal therapy for localized prostate cancer using either high intensity focused ultrasound or cryotherapy A Stabile, R Sanchez-Salas, R Tourinho-Barbosa, P Macek, F Pellegrino, ... The Journal of Urology 206 (3), 638-645, 2021 | 10 | 2021 |
| Holmium laser enucleation of the prostate is associated with complications and sequelae even in the hands of an experienced surgeon following completion of the learning curve P Capogrosso, E Ventimiglia, G Fallara, N Schifano, A Costa, L Candela, ... European Urology Focus 9 (5), 813-821, 2023 | 9 | 2023 |
| Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? E Mazzone, A Stabile, G Sorce, F Pellegrino, F Barletta, G Motterle, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 784. e1-784. e9, 2021 | 9 | 2021 |
| A mechanistic insight into the anti-metastatic role of the prostate specific antigen F Pellegrino, A Coghi, G Lavorgna, W Cazzaniga, E Guazzoni, I Locatelli, ... Translational oncology 14 (11), 101211, 2021 | 8 | 2021 |
| Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series A Stabile, F Barletta, G Motterle, F Pellegrino, G Sorce, E Mazzone, ... Prostate Cancer and Prostatic Diseases 24 (4), 1137-1142, 2021 | 7 | 2021 |
| Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data G Gandaglia, F Pellegrino, A Golozar, B De Meulder, T Abbott, A Achtman, ... European Urology 85 (5), 457-465, 2024 | 5 | 2024 |
| Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution … F Pellegrino, A Stabile, E Mazzone, G Sorce, F Barletta, M De Angelis, ... The Prostate 82 (12), 1170-1175, 2022 | 5 | 2022 |
| Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of … UG Falagario, A Martini, F Pellegrino, G Carrieri, M Manon, A Lantz, ... European Urology Oncology 7 (1), 167-168, 2024 | 3 | 2024 |
| Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes F Piramide, F Turri, D Amparore, G Fallara, R De Groote, S Knipper, ... European Urology, 2023 | 3 | 2023 |
